More about
Angiotensin Receptor Blockers
News
December 07, 2020
1 min read
Save
Top in cardiology: ACE inhibitors, ARBs and COVID-19, women at higher risk for CVD
A study that indicated using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers was not linked to an increased rate of COVID-19 infection or mortality was the top story in cardiology last week.
Part of the Healio Network
Angiotensin Receptor Blockers (ARBs)
Angiotensin receptor blockers (ARBs) are a class of oral medications that act primarily through blockade of the angiotensin receptor.